Second-line, low-dose, weekly paclitaxel
β
Mark A. Socinski; Michael J. Schell; Kamal Bakri; Amy Peterman; Ji-Hyun Lee; Pau
π
Article
π
2002
π
John Wiley and Sons
π
English
β 83 KB
π 2 views
## Abstract ## BACKGROUND Secondβline chemotherapy with docetaxel improves survival and quality of life (QoL) in patients with nonsmall cell lung carcinoma (NSCLC) who fail firstβline platinumβbased regimens. The authors sought to determine the activity of secondβline, lowβdose, weekly paclitaxel